...
首页> 外文期刊>BMC Complementary and Alternative Medicine >Anti-hyperglycaemic effects of herbal porridge made of Scoparia dulcis leaf extract in diabetics – a randomized crossover clinical trial
【24h】

Anti-hyperglycaemic effects of herbal porridge made of Scoparia dulcis leaf extract in diabetics – a randomized crossover clinical trial

机译:Scoparia dulcis叶提取物制成的中药粥对糖尿病患者的降血糖作用–一项随机交叉临床试验

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Leaf extracts of Scoparia dulcis , is used as a herbal remedy by diabetics worldwide. Fresh Scoparia dulcis porridge elicited a low glycaemic index (GI) and anti-hyperglycaemic effects when fed to diabetic Wistar rats. Commercially produced Scoparia dulcis porridge (SDC) elicited medium GI. Present study was aimed at studying the anti-diabetic effects of consumption of commercially produced S. dulcis porridge. Method A randomized crossover clinical trial with type 2 diabetic patients ( n =?35) on medication, with mild and moderate diabetes [fasting blood glucose (FBG) 126–300?mg/dL, age 35–70 years] was conducted. Within the first three months (study period 1) group 1 was the test and group 2 was the control. Following a wash-out period, the two groups were crossed over (study period 2: group 1 – control; group 2 - test). Test group consumed commercially produced SDC for 3?days/week for three months and the control group any other food. At the onset and end of each study period glucose measurements [Fasting Blood Glucose (FBG), HbA1c], lipid measurements (total cholesterol, HDL-C, LDL-C, triglycerides, cholesterol ratios), toxicity parameters (liver enzymes, creatinine, CRP, eGFR) were analyzed by enzyme assay kit methods using a KONELAB 20XT auto analyzer. Significances between groups were analyzed by one way ANOVA (normal distribution) and Mann Whitney test (if the values were not normally distributed). Within group comparisons were carried out by Bonferroni post hoc test. Results During the crossover clinical trial HbA1c of group 1 decreased from 7.9?±?0.5 to 6.5?±?0.3 ( p =?0.003) while HbA1c of group 2 decreased from 7.0?±?0.3to 6.7?±?0.3 while in the test group. Therefore, both test groups (1 and 2) elicited a decrease in HbA1c compared to respective control groups. Both test groups elicited a non significant decrease in FBG following the intervention (group 1 - from 174?±?14 to 160?±?10?mg/dL; group 2 - from 183?±?13 to 160?±?7?mg/dL). No significant differences ( p >0.05) in insulin, cholesterol measurements (total cholesterol, LDL-C, HDL-C, triglycerides and cholesterol ratios) and atherogenic index between or within groups were observed. All other measurements (AST, ALT, ALP, creatinine, CRP, eGFR) were normal and not significantly different between or within groups. Conclusion Porridge made with SDC leaf extract decreased FBG and HbA1c ( p >0.05) of type 2 diabetic patients. The porridge had no effect on cholesterol measurements and no toxicity was observed at the dose tested. Therefore, the SDC porridge can be recommended as a suitable meal for diabetic patients.
机译:背景Scoparia dulcis的叶提取物被全世界的糖尿病患者用作草药。当饲喂糖尿病Wistar大鼠时,新鲜的Scoparia dulcis粥会引起低血糖指数(GI)和抗高血糖作用。商业生产的Scoparia dulcis粥(SDC)引发了GI。当前的研究旨在研究食用商业生产的S. dulcis粥的抗糖尿病作用。方法对患有轻度和中度糖尿病[空腹血糖(FBG)126-300?mg / dL,年龄35-70岁]的2型糖尿病患者(n = 35)进行了一项随机交叉临床试验。在头三个月(研究期1)内,第1组为测试组,第2组为对照组。冲洗期过后,将两组进行交叉研究(研究期2:组1 –对照;组2 –测试)。测试组食用商业生产的SDC,每周3天,连续3个月,对照组食用其他食物。在每个研究阶段的开始和结束时,都要进行葡萄糖测定[速食血糖(FBG),HbA1c],脂质测定(总胆固醇,HDL-C,LDL-C,甘油三酸酯,胆固醇比),毒性参数(肝酶,肌酐,使用KONELAB 20XT自动分析仪通过酶分析试剂盒方法分析CRP,eGFR)。通过ANOVA(正态分布)和Mann Whitney检验(如果值不是正态分布)分析组之间的显着性。组内比较通过Bonferroni事后检验进行。结果在交叉临床试验中,第1组的HbA1c从7.9?±?0.5降低至6.5?±?0.3(p =?0.003),而第2组的HbA1c从7.0?±?0.3降至6.7?±?0.3,而在HbA1c中测试组。因此,与相应的对照组相比,两个测试组(1和2)均引起HbA1c降低。干预后,两个测试组的FBG均无显着降低(第1组-从174?±?14降至160?±?10?mg / dL;第2组-从183?±?13降至160?±?10?mg / dL。毫克/分升)。两组之间或组之间的胰岛素,胆固醇测量值(总胆固醇,LDL-C,HDL-C,甘油三酸酯和胆固醇比率)和动脉粥样硬化指数均无显着差异(p> 0.05)。所有其他指标(AST,ALT,ALP,肌酐,CRP,eGFR)均正常,两组之间或组内均无显着差异。结论SDC叶提取物制成的粥可降低2型糖尿病患者的FBG和HbA1c(p> 0.05)。粥对胆固醇的测定没有影响,并且在所测试的剂量下未观察到毒性。因此,可以建议将SDC粥作为适合糖尿病患者的餐食。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号